The global cholera vaccines market size reached US$ 4.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Million by 2028, exhibiting a growth rate (CAGR) of 11.1% during 2023-2028. More Info:- https://www.imarcgroup.com/cholera-vaccines-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Cholera Vaccines
Market Research and
Forecast Report 2023-2028
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Cholera Vaccines Market Research Report:
The latest report by IMARC, titled “Cholera Vaccines Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028” " the global cholera vaccines market reached a value of
US$ 4.9 Million in 2022.
Cholera is an acute intestinal disease that is generally caused by the consumption of contaminated
water and food. It is spread by the Vibrio Cholerae bacteria that leads to pain in the abdomen,
diarrhea, nausea, vomiting and water-electrolyte imbalance. Cholera vaccines are effective in
stimulating the production of antibodies that aid in preventing the disease among individuals. Widely
prepared using the live cholera-causing bacteria to aid in developing immunity against the same, these
vaccines are directly injected intramuscularly or intradermally in the body.
Request Free Sample Report: https://www.imarcgroup.com/cholera-vaccines-market/requestsample

4. Report Description
Report Description and Highlights
Global Cholera Vaccines Market Trends:
The global market is primarily driven by the escalating prevalence of cholera among the masses. This can be
attributed to the poor sanitation and hygiene conditions in rural and geographically extended areas. Moreover, the
rising awareness regarding the availability of cholera vaccines among the masses has propelled the product demand.
In line with this, numerous initiatives undertaken by several government agencies and non-government organizations
(NGOs) across multiple countries for conducting immunization programs are providing a boost to the demand for
cholera vaccines.
Along with this, the increasing investments and funding by public and private agencies for conducting extensive
research and development (R&D) activities are favorably impacting the market. Other factors, including the
expanding healthcare expenditure, a considerable increase in water pollution levels, and the rising number of
research laboratories and diagnosis centers, are also positively influencing the market growth. On account of the
aforementioned factors, the market is anticipated to reach a value of US$ 9.2 Million by 2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Vaccine Type:
• Whole Cell V. Cholerae O1 with Recombinant B-Subunit
• Killed Oral O1 and O139
Breakup by Product:
• Dukoral
• Shanchol
• Vaxchora
• Euvichol and Euvichol-Plus
• Others
Breakup by End User:
• Hospitals and Clinics
• Research and Academic Laboratories
• Others
Breakup by Region:

6. Report Description
Report Description and Highlights
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America

7. Report Description
Report Description and Highlights
• Brazil
• Mexico
• Others
• Middle East and Africa

8. Competitive Landscape with Key Players:
• Astellas Pharma Inc
• Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
• Emergent BioSolutions Inc.
• Eubiologics Co. Ltd.
• Johnson & Johnson
• Merck & Co. Inc
• Pfizer Inc.
• PharmaChoice Canada Inc
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Valneva SE.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cholera-vaccines-market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us